Visfatin can lead to insulin resistance, which results in the progression of diabetes, affecting lipid metabolism, which is associated with the development of obesity and the invasion of immune cells into tissues, leading to an increased inflammatory response [15, 20, 22]. The gene discussed is NAMPT; the disease is obesity due to melanocortin 4 receptor deficiency.